The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.

Clinical trial NCT02710747 · UNKNOWN

Trial details

NCT number: NCT02710747
Sponsor: Guangdong Provincial People's Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Valve Disease Older Than 18-years-old Without Any Liver or Kidney Diseases

Start date: 2015-01-01
Primary completion: 2016-06-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.